Whole-exome sequencing (WES) identified MAPT IVS10 + 16C>T heterozygous mutation (a previously reported pathogenic variant for FTD) and APOE ε2/ε3 genotype (ApoE2), confirming the diagnosis of bvFTD. The gene discussed is MAPT; the disease is frontotemporal dementia.